Literature DB >> 2449433

The molecular organization of human alpha 2-macroglobulin. An immunoelectron microscopic study with monoclonal antibodies.

E Delain1, M Barray, J Tapon-Bretaudiere, F Pochon, P Marynen, J J Cassiman, H Van den Berghe, F Van Leuven.   

Abstract

To study the three-dimensional organization of alpha 2-macroglobulin (alpha 2M) from human plasma, immunoelectron microscopy of negatively stained specimens was used. A panel of monoclonal antibodies (mAb) with specificities typical for the two major conformers of alpha 2M (native and protease-transformed) was explored. The mAb have been selected and were classified biochemically as specific for either native or transformed alpha 2M or as reactive with both conformers. Furthermore, among the mAb that were specific for the proteinase-transformed form of alpha 2M, those reacting with the 20-kDa receptor-binding domain were considered a fourth category. Immunoelectron microscopy with these 20-kDa receptor-binding domain-specific mAb yielded the most typical result: predominantly, individual H-like alpha 2M-chymotrypsin molecules were complexed with two IgG molecules, each one bound to the extremities of two arms of the H-like figure. The resulting planar complex has the appearance of a dumbbell. Since this was observed with eight different mAb of this specificity, the result is interpreted to mean that the 20-kDa receptor-binding domain is compact and constitutes the outermost domain at the extremes of the arms of the H-like transformed alpha 2M. The mAb which are specific for the transformed state of alpha 2M but which do not react with the 20-kDa receptor-binding domain, also bound at the arms of the H-like figure, but at nonterminal positions. Moreover, these mAb produced mostly linear, chain-like immune complexes of numerous H-like alpha 2M molecules cross-linked by the IgG. The large category of mAb that reacted with both conformers of alpha 2M (native and proteinase complex) were observed to make various types of immune complexes with intra- and intermolecular cross-linking by the IgG. The observations of reaction of these mAb with Cd2+-induced dimers (half-molecules of alpha 2M), either native or transformed, proved helpful and, for certain mAb, essential to understand the organization of the alpha 2M-IgG complexes. Combined, the observations allow us to propose new models for the three-dimensional organization of native and chymotrypsin-transformed dimeric and tetrameric human alpha 2M.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449433

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Structure of a rat α₁-macroglobulin receptor-binding domain dimer.

Authors:  T Xiao; D L DeCamp; S R Sprang
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

2.  Beta-amyloid peptide binds equivalently to binary and ternary alpha2-macroglobulin-protease complexes.

Authors:  Joseph M Mettenburg; Steven L Gonias
Journal:  Protein J       Date:  2005-02       Impact factor: 2.371

3.  The structure of alpha 2-macroglobulin-methylamine after papain digestion as determined by electron microscopy.

Authors:  I M Hussaini; N L Figler; S L Gonias
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

4.  Cryo-EM structures show the mechanistic basis of pan-peptidase inhibition by human α2-macroglobulin.

Authors:  Daniel Luque; Theodoros Goulas; Carlos P Mata; Soraia R Mendes; F Xavier Gomis-Rüth; José R Castón
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-02       Impact factor: 12.779

5.  Structural Mechanics of the Alpha-2-Macroglobulin Transformation.

Authors:  Yasuhiro Arimura; Hironori Funabiki
Journal:  J Mol Biol       Date:  2021-12-20       Impact factor: 5.469

6.  Conformational states of a bacterial α2-macroglobulin resemble those of human complement C3.

Authors:  David Neves; Leandro F Estrozi; Viviana Job; Frank Gabel; Guy Schoehn; Andréa Dessen
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.